Cargando…
Cryo-ablation improves anti-tumor immunity through recovering tumor educated dendritic cells in tumor-draining lymph nodes
BACKGROUND: In addition to minimally invasive destruction of tumors, cryo-ablation of tumors to some extent modulated anti-tumor immunity. Cryo-ablated tumors in glioma mice models induced anti-tumor cellular immunologic response which increases the percentage of CD3(+) and CD4(+)T cells in blood as...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4362656/ https://www.ncbi.nlm.nih.gov/pubmed/25792805 http://dx.doi.org/10.2147/DDDT.S76592 |
_version_ | 1782361834932666368 |
---|---|
author | He, Xiao-Zheng Wang, Qi-Fu Han, Shuai Wang, Hui-Qing Ye, Yong-Yi Zhu, Zhi-Yuan Zhang, Shi-Zhong |
author_facet | He, Xiao-Zheng Wang, Qi-Fu Han, Shuai Wang, Hui-Qing Ye, Yong-Yi Zhu, Zhi-Yuan Zhang, Shi-Zhong |
author_sort | He, Xiao-Zheng |
collection | PubMed |
description | BACKGROUND: In addition to minimally invasive destruction of tumors, cryo-ablation of tumors to some extent modulated anti-tumor immunity. Cryo-ablated tumors in glioma mice models induced anti-tumor cellular immunologic response which increases the percentage of CD3(+) and CD4(+)T cells in blood as well as natural killer cells. As a crucial role in triggering anti-tumor immunity, dendritic cells (DCs) were educated by tumors to adopt a tolerance phenotype which helps the tumor escape from immune monitoring. This study aims to study whether cryo-ablation could influence the tolerogenic DCs, and influence anti-tumor immunity in tumor-draining lymph nodes (TDLNs). METHODS: Using the GL261 subcutaneous glioma mouse model, we created a tumor bearing group, cryo-ablation group, and surgery group. We analyzed alteration in phenotype and function of tolerogenic DCs, and evaluated the factors of anti-tumor immunity inhibition. RESULTS: DCs in TDLNs in GL261 subcutaneous glioma mouse model expressed tolerogenic phenotype. In contrast to surgery, cryo-ablation improved the quantity and quality of these tolerogenic DCs. Moreover, the DCs decreased the expression of intracellular interleukin-10 (IL-10) and extra-cellular IL-10. In vitro, DCs from the cryo-ablation group recovered their specific function and induced potent anti-tumor immunity through triggering T cells. In vivo, cryo-ablation showed weak anti-tumor immunity, only inhibiting the growth of rechallenged tumors. But many IL-10-low DCs, rather than IL-10-high DCs, infiltrated the tumors. More importantly, Tregs inhibited the performance of these DCs; and depletion of Tregs greatly improved anti-tumor immunity in vivo. CONCLUSION: Cryo-ablation could recover function of tumor induced tolerogenic DCs in vitro; and depletion of Tregs could improve this anti-tumor effect in vivo. The Tregs/CD4(+)T and Tregs/CD25(+)T cells in TDLNs inhibit DCs’ activity and function. |
format | Online Article Text |
id | pubmed-4362656 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-43626562015-03-19 Cryo-ablation improves anti-tumor immunity through recovering tumor educated dendritic cells in tumor-draining lymph nodes He, Xiao-Zheng Wang, Qi-Fu Han, Shuai Wang, Hui-Qing Ye, Yong-Yi Zhu, Zhi-Yuan Zhang, Shi-Zhong Drug Des Devel Ther Original Research BACKGROUND: In addition to minimally invasive destruction of tumors, cryo-ablation of tumors to some extent modulated anti-tumor immunity. Cryo-ablated tumors in glioma mice models induced anti-tumor cellular immunologic response which increases the percentage of CD3(+) and CD4(+)T cells in blood as well as natural killer cells. As a crucial role in triggering anti-tumor immunity, dendritic cells (DCs) were educated by tumors to adopt a tolerance phenotype which helps the tumor escape from immune monitoring. This study aims to study whether cryo-ablation could influence the tolerogenic DCs, and influence anti-tumor immunity in tumor-draining lymph nodes (TDLNs). METHODS: Using the GL261 subcutaneous glioma mouse model, we created a tumor bearing group, cryo-ablation group, and surgery group. We analyzed alteration in phenotype and function of tolerogenic DCs, and evaluated the factors of anti-tumor immunity inhibition. RESULTS: DCs in TDLNs in GL261 subcutaneous glioma mouse model expressed tolerogenic phenotype. In contrast to surgery, cryo-ablation improved the quantity and quality of these tolerogenic DCs. Moreover, the DCs decreased the expression of intracellular interleukin-10 (IL-10) and extra-cellular IL-10. In vitro, DCs from the cryo-ablation group recovered their specific function and induced potent anti-tumor immunity through triggering T cells. In vivo, cryo-ablation showed weak anti-tumor immunity, only inhibiting the growth of rechallenged tumors. But many IL-10-low DCs, rather than IL-10-high DCs, infiltrated the tumors. More importantly, Tregs inhibited the performance of these DCs; and depletion of Tregs greatly improved anti-tumor immunity in vivo. CONCLUSION: Cryo-ablation could recover function of tumor induced tolerogenic DCs in vitro; and depletion of Tregs could improve this anti-tumor effect in vivo. The Tregs/CD4(+)T and Tregs/CD25(+)T cells in TDLNs inhibit DCs’ activity and function. Dove Medical Press 2015-03-10 /pmc/articles/PMC4362656/ /pubmed/25792805 http://dx.doi.org/10.2147/DDDT.S76592 Text en © 2015 He et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research He, Xiao-Zheng Wang, Qi-Fu Han, Shuai Wang, Hui-Qing Ye, Yong-Yi Zhu, Zhi-Yuan Zhang, Shi-Zhong Cryo-ablation improves anti-tumor immunity through recovering tumor educated dendritic cells in tumor-draining lymph nodes |
title | Cryo-ablation improves anti-tumor immunity through recovering tumor educated dendritic cells in tumor-draining lymph nodes |
title_full | Cryo-ablation improves anti-tumor immunity through recovering tumor educated dendritic cells in tumor-draining lymph nodes |
title_fullStr | Cryo-ablation improves anti-tumor immunity through recovering tumor educated dendritic cells in tumor-draining lymph nodes |
title_full_unstemmed | Cryo-ablation improves anti-tumor immunity through recovering tumor educated dendritic cells in tumor-draining lymph nodes |
title_short | Cryo-ablation improves anti-tumor immunity through recovering tumor educated dendritic cells in tumor-draining lymph nodes |
title_sort | cryo-ablation improves anti-tumor immunity through recovering tumor educated dendritic cells in tumor-draining lymph nodes |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4362656/ https://www.ncbi.nlm.nih.gov/pubmed/25792805 http://dx.doi.org/10.2147/DDDT.S76592 |
work_keys_str_mv | AT hexiaozheng cryoablationimprovesantitumorimmunitythroughrecoveringtumoreducateddendriticcellsintumordraininglymphnodes AT wangqifu cryoablationimprovesantitumorimmunitythroughrecoveringtumoreducateddendriticcellsintumordraininglymphnodes AT hanshuai cryoablationimprovesantitumorimmunitythroughrecoveringtumoreducateddendriticcellsintumordraininglymphnodes AT wanghuiqing cryoablationimprovesantitumorimmunitythroughrecoveringtumoreducateddendriticcellsintumordraininglymphnodes AT yeyongyi cryoablationimprovesantitumorimmunitythroughrecoveringtumoreducateddendriticcellsintumordraininglymphnodes AT zhuzhiyuan cryoablationimprovesantitumorimmunitythroughrecoveringtumoreducateddendriticcellsintumordraininglymphnodes AT zhangshizhong cryoablationimprovesantitumorimmunitythroughrecoveringtumoreducateddendriticcellsintumordraininglymphnodes |